Our team of experts brings you cancer-related news and research updates.
Latest data shows improvements for cervical cancer are linked to HPV vaccine and downturns in prostate cancer are driven by advanced-stage disease.
Only about 30% of adolescents who live in rural Oregon are up to date with the HPV vaccine. Learn how the RAVE Study is helping uncover vaccine barriers & solutions.
Read the Cancer Facts & Figures 2021, for the latest estimates, information and statistics for deaths related to cancer.
A study using data from the Centers for Disease Control and Prevention (CDC) provides evidence that the human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical precancer – lesions that can become cervical cancer.
Cancers in adolescents and young adults (AYAs)—in ages 15 to 39—are the focus of a new report published in CA: A Cancer Journal for Clinicians on September 17, 2020. The researchers looked at rates and trends by sex and race/ethnicity, across 3 smaller age groups: Ages 15 to 19 (referred to as adolescents or teens), ages 20 to 29, and ages 30 to 39.
The American Cancer Society (ACS) has updated its screening guideline for cervical cancer. The new guideline is for people with a cervix with an average risk of cervical cancer.
The American Cancer Society (ACS) has updated its guideline for human papilloma virus (HPV) vaccination. New recommendations are for healthcare providers to routinely offer the HPV vaccine series to boys and girls between ages 9 and 12.
When Coral Conway was diagnosed with stage IIIB cervical cancer, she felt overwhelmed. She was getting advice and information from many different sources. She had visited local doctors and hospitals in Florida and talked with professionals in her home country of Argentina.